High frequency SD-OCT follow-up leading to up to biweekly intravitreal ranibizumab treatment in neovascular age-related macular degeneration

A remarkable proportion of neovascular age-related macular degeneration (nAMD) patients respond rather poorly to ranibizumab treatment, in spite of the minimum 4-week follow-up and treatment interval. Usually, retreatments are based on nAMD activity as evaluated by Spectral-domain Optical coherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuerksever, Cengiz, Pruente, Christian, Hatz, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994577/
https://www.ncbi.nlm.nih.gov/pubmed/33767261
http://dx.doi.org/10.1038/s41598-021-86348-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994577/
https://www.ncbi.nlm.nih.gov/pubmed/33767261
http://dx.doi.org/10.1038/s41598-021-86348-2

Ejemplares similares